Does Retention and Remission Rates to 2nd and 3rd TNF Inhibitors in Patients with Axial Spondyloarthritis Depend on the Reason from Withdrawal to the Previous Treatment? - Real World Data from 12 European Countries in the EuroSpA Research Collaboration
Annual Meeting of the American-College-of-Rheumatology/Association-of-Rheumatology-Professionals (ACR/ARP), Georgia, United States Of America, 8 - 13 November 2019